Page last updated: 2024-10-27

fluoxetine and Leukemia, Basophilic, Acute

fluoxetine has been researched along with Leukemia, Basophilic, Acute in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Leukemia, Basophilic, Acute: A rare acute myeloid leukemia in which the primary differentiation is to BASOPHILS. It is characterized by an extreme increase of immature basophilic granulated cells in the bone marrow and blood. Mature basophils are usually sparse.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baik, SY1
Jung, KH1
Choi, MR1
Yang, BH1
Kim, SH1
Lee, JS1
Oh, DY1
Choi, IG1
Chung, H1
Chai, YG1

Other Studies

1 other study available for fluoxetine and Leukemia, Basophilic, Acute

ArticleYear
Fluoxetine-induced up-regulation of 14-3-3zeta and tryptophan hydroxylase levels in RBL-2H3 cells.
    Neuroscience letters, 2005, Feb-01, Volume: 374, Issue:1

    Topics: 14-3-3 Proteins; Animals; Antidepressive Agents, Second-Generation; Cell Line, Tumor; Dose-Response

2005